stockrow
Saturday 7 November 2026
Export RHEP’s income statement to Excel — free account
Adcare Health Systems Inc
RHEP Healthcare Medical Care Facilities
Adcare Health Systems Inc’s revenue for fiscal 2025 (year ended December 2025) was $53.2 million, up 189.9% from fiscal 2024.
- Revenue
- +143.0%
- EPS
- +70.6%
- Free cash flow
- +224.5%
- Total debt
- −13.0%
Quarter to June 2026, against a year earlier
1.00
0.00
0.00%
Follow RHEP
Alert me
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
2.56 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Piotroski F-Score |
5 | 5 | 5 | 2 | 3 | 5 | 5 | 3 | 5 | 4 |
Altman Z-Score |
(0.93) | (1.90) | (1.36) | (2.22) | (1.09) | (1.14) | (1.00) | (1.43) | (1.14) | (0.75) |
P/S ratio |
0.07 | 0.16 | 0.23 | 0.15 | 0.29 | 0.34 | 0.12 | 0.12 | 0.15 | 1.12 |
P/FCF ratio |
0.52 | 2.05 | 1.42 | 0.00 | 1.64 | 7.15 | 0.47 | 2.59 | 1.32 | 2.30 |
Altman Z″-Score (non-manufacturers) |
(4.52) | (6.09) | (3.19) | (6.33) | (3.00) | (2.85) | (2.60) | (3.76) | (3.63) | (2.98) |
P/Operating CF |
(2.84) | 3.04 | 15.49 | (3.85) | 10.00 | 15.94 | 1.95 | 2.03 | 2.42 | (11.30) |
Beneish M-Score |
(0.24) | (1.25) | (4.29) | (1.47) | (2.29) | (1.33) | (1.20) | (3.27) | (3.11) | (2.09) |
P/B ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
0.79 | 2.74 | 2.52 | 1.56 | 2.22 | 3.50 | 2.47 | 3.58 | 2.69 | 3.31 |
EV/EBITDA |
10.79 | 21.84 | 28.69 | 0.00 | 11.33 | 11.57 | 5.46 | 17.87 | 6.53 | 8.41 |
EV/Operating CF |
(18.63) | 25.82 | 11.66 | (15.61) | 12.08 | 47.51 | 20.74 | 58.54 | 13.13 | (26.79) |
EV/FCF |
6.13 | 35.50 | 15.72 | (14.48) | 12.39 | 72.81 | 9.89 | 78.13 | 23.10 | 6.78 |
Quick Ratio |
0.52 | 0.29 | 0.85 | 0.88 | 1.37 | 1.83 | 1.31 | 0.72 | 0.19 | 0.72 |
Current Ratio |
0.67 | 0.33 | 2.72 | 1.04 | 1.47 | 1.98 | 1.47 | 1.08 | 0.24 | 0.81 |
Net Debt/EBITDA |
9.87 | 20.58 | 25.57 | (11.69) | 9.83 | 10.44 | 5.20 | 22.92 | 6.16 | 5.55 |
Debt/Assets |
63.64% | 82.23% | 68.78% | 79.54% | 57.86% | 58.29% | 48.67% | 107.10% | 62.39% | 63.57% |
Debt/Equity |
123.65 | (17.03) | 231.16 | 14.68 | 5.88 | 5.67 | 4.71 | 17.51 | 3.72 | (2.00) |
Asset Turnover |
0.83 | 0.30 | 0.26 | 0.41 | 0.25 | 0.16 | 0.19 | 0.21 | 0.22 | 0.19 |
Operating CF/Net income |
(0.74) | (0.60) | 0.09 | 0.23 | (0.48) | (0.13) | (0.69) | (0.07) | (0.60) | 0.23 |
Capex/Depreciation |
4.08 | (0.25) | (0.41) | (0.11) | (0.05) | (0.15) | 0.72 | (0.06) | (0.43) | 2.66 |
Interest Coverage |
0.62 | 0.06 | (0.30) | (2.70) | 0.95 | 0.83 | 1.04 | (0.13) | 1.25 | 0.63 |
| (16.73%) | 15.78% | (101.89%) | 28.65% | 19.70% | 18.99% | 6.54% | 39.43% | 20.85% | 47.90% | |
| 4.75% | (5.25%) | 60.43% | (18.21%) | (9.53%) | (8.73%) | (3.26%) | (19.20%) | (7.61%) | (10.25%) | |
ROIC |
2.68% | 0.23% | (1.32%) | (7.84%) | 2.57% | 2.15% | 5.78% | (0.46%) | 3.94% | 12.63% |
Return on Tangible Assets |
10.90% | (16.17%) | 85.83% | (33.68%) | (18.78%) | (16.80%) | (6.04%) | (25.46%) | (12.95%) | (19.90%) |
Average Days of Receivables |
55.10 | 66.93 | 29.84 | 63.90 | 29.33 | 43.60 | 17.46 | 16.08 | 13.72 | 32.12 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
22.65% | 29.50% | 31.53% | 12.95% | 14.73% | 19.19% | 15.85% | 16.75% | 15.33% | 27.95% |
Intangible Assets out of Total Assets |
0.09 | 0.07 | 0.07 | 0.06 | 0.04 | 0.04 | 0.04 | 0.05 | 0.06 | 0.06 |
Share Based Compensation of Revenue |
0.44% | 0.62% | 2.08% | 0.65% | 1.80% | 0.28% | 0.46% | 0.80% | 1.06% | 4.10% |
Graham Net Nets |
(12.95) | (19.51) | (11.31) | (9.63) | (10.55) | (14.32) | (38.90) | (31.85) | (21.80) | (4.42) |
Graham Number |
0.00 | 21.44 | 27.28 | 81.50 | 62.95 | 62.66 | 22.31 | 94.86 | 55.95 | 67.66 |
Earnings Yield |
39.06% | (110.90%) | (158.36%) | (289.00%) | (130.16%) | (160.34%) | (52.64%) | (763.61%) | (221.55%) | (47.45%) |
Free Cash Flow Yield |
191.26% | 48.75% | 70.54% | (70.65%) | 61.01% | 13.98% | 212.64% | 38.63% | 75.92% | 43.40% |
Revenue per Share |
18.95 | 9.87 | 9.14 | 20.23 | 15.39 | 10.41 | 11.93 | 13.15 | 15.21 | 16.66 |
Operating CF per Share |
(0.81) | 1.05 | 1.98 | (2.02) | 2.82 | 0.77 | 1.42 | 0.80 | 3.11 | (2.06) |
Capex per Share |
3.25 | (0.29) | (0.51) | (0.16) | (0.07) | (0.27) | 1.56 | (0.20) | (1.34) | 10.18 |
Free Cash Flow per Share |
2.45 | 0.76 | 1.47 | (2.18) | 2.75 | 0.50 | 2.98 | 0.60 | 1.77 | 8.12 |
Cash per Share |
1.66 | 1.32 | 2.23 | 2.20 | 5.68 | 4.44 | 4.76 | 3.87 | 1.68 | 9.44 |
Shareholders Equity per Share |
0.12 | (1.57) | 0.10 | 2.09 | 6.00 | 6.58 | 6.96 | 3.67 | 10.81 | (22.90) |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.12 | (1.57) | 0.10 | 2.09 | 6.00 | 6.58 | 6.96 | 3.67 | 10.81 | (22.90) |
Free Cash Flow |
6.87 | 1.41 | 2.75 | (3.88) | 4.77 | 0.85 | 5.03 | 1.01 | 2.92 | 13.46 |
Working Capital |
(7.87) | (13.59) | 11.28 | 0.49 | 4.08 | 5.13 | 3.24 | 0.84 | (14.79) | (4.80) |
Capital Expenditures |
9.13 | (0.53) | (0.96) | (0.28) | (0.12) | (0.45) | 2.63 | (0.34) | (2.22) | 16.87 |
Net Current Asset Value |
(51.17) | (56.56) | (44.16) | (52.82) | (82.48) | (86.56) | (91.92) | (83.27) | (83.98) | (136.96) |
EV/EBIT |
25.30 | 311.56 | 0.00 | 0.00 | 23.34 | 26.82 | 9.10 | 0.00 | 13.15 | 20.21 |
Capex to Sales |
(0.17) | 0.03 | 0.06 | 0.01 | 0.00 | 0.03 | (0.13) | 0.02 | 0.09 | (0.61) |
Price to Operating Income |
2.16 | 18.00 | 0.00 | 0.00 | 3.09 | 2.63 | 0.43 | 0.00 | 0.75 | 6.86 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.06 | 0.06 | 0.07 | 0.05 | 0.05 | 0.06 | 0.07 | 0.07 | 0.06 | 0.08 |
Cash ROIC |
14.26% | 2.87% | 5.84% | (6.24%) | 5.86% | 1.04% | 6.69% | 0.84% | 3.36% | 25.09% |
Accounts Receivable Turnover |
9.34 | 7.70 | 4.46 | 8.52 | 12.57 | 11.48 | 20.82 | 23.01 | 14.91 | 4.91 |
Accounts Payable Turnover |
7.07 | 3.05 | 2.96 | 5.98 | 2.93 | 0.20 | 0.16 | 0.15 | 0.17 | 0.00 |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Average Days of Payables |
67.52 | 142.84 | 106.13 | 57.04 | 138.01 | 1,626.55 | 2,042.56 | 2,494.93 | 2,525.06 | 0.00 |
Days of Inventory on Hand |
13.09 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Average Receivables |
5.69 | 2.38 | 3.85 | 4.22 | 2.12 | 1.53 | 0.97 | 0.96 | 1.69 | 5.62 |
Average Payables |
5.34 | 3.09 | 2.89 | 3.52 | 3.38 | 3.35 | 4.03 | 4.37 | 3.71 | 7.45 |
Average Assets |
64.14 | 61.32 | 65.38 | 87.14 | 106.86 | 110.89 | 107.16 | 103.56 | 113.02 | 144.38 |
Average Common Equity |
(18.20) | (20.39) | (38.77) | (55.37) | (51.67) | (51.00) | (53.48) | (50.41) | (41.25) | (30.89) |
Columns are period end dates · fundamentals updated 25 Oct 2026